Finally, we investigated if IFNL1 or IFNL2 levels were associated with disease severity in COVID-19 patients using good (WHO 1–2), mild (WHO 3–4), and bad (WHO 5–8) clinical outcomes to stratify the large cohort of Irish patients (n = 399). Here, IFNL1 is linked to COVID-19.